Microchip Technology Inc. vs Smith & Nephew plc — how do they compare? Microchip Technology Inc. trades at $78.16 (market cap $43.99B), while Smith & Nephew plc trades at $30.14 (market cap $12.38B). The key difference: Microchip Technology Inc. is far larger — about 3.6× Smith & Nephew plc's market cap, and Smith & Nephew plc pays the higher dividend (2.66%). Which is the better fit depends on your goals.
| MCHP | SNN | |
|---|---|---|
Market Cap | $43.99B | $12.38B |
Sector | Technology | Health |
52-Week High | $102.97 | $38.70 |
52-Week Low | $49.02 | $28.73 |
Enterprise Value | $49.12B | $15.41B |
Dividend Yield | 2.25% | 2.66% |
Trailing returns across standard periods
Latest headlines on both assets
Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.
Read more on MCHP →Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →